Diabetes; thyroid disease; obesity; pituitary disease; lipid disorders; adrenal diseases; adolescents with diabetes
Drug development for the treatment of type 2 diabetes mellitus.
Thyroid nodules, thyroid cancer, diabetes mellitus
Diabetes mellitus and preventive cardiology
Osteoporosis, Paget's Disease of Bone
Thyroid funtion testing methodology
Phase III Studies of Pharmaceutical Agents in the Treatment of Postmenopausal Osteoporosis.
The Roe laboratory studies signal transduction mechanisms that regulate pancreatic beta cell biology and the pathophysiology of diabetes.
Type 1 Diabetes
Pathophysiology and treatment of pituitary and growth disorders. Best practices care for: late endocrine effects of treatment of childhood malignancies; disorders of sex development.
My research focuses on the psychosocial issues that affect patients with diabetes and those at risk for diabetes. In my work, we are developing and testing effective and practical interventions for patients with diabetes, those at risk, and their partners, to help them achieve better physical health (e.g., control of blood sugar, weight) and quality of life. We are also seeking to understand how depression and anxiety may interfere with the health of diabetes patients.
Diabetes and its complications, lipid disorders, obesity, metabolism, metabolic bones diseases including osteoporosis